Our immune system is an evolutionary masterpiece. Every day it protects us from the thousands of different viruses, bacteria and other microbes that attempt to invade our bodies. Without a functioning immune system, we would not survive.
One of the immune system’s marvels is its ability to identify pathogens and differentiate them from the body’s own cells. The microbes that threaten our health do not wear a uniform – they all have different appearances. Many have also developed similarities to human cells, as a form of camouflage. So how does the immune system keep track of what to attack and what to protect? Why doesn’t the immune system attack our bodies more frequently?
Researchers long believed they knew the answer to these questions: that immune cells mature through a process called central immune tolerance (see image). However, our immune system turned out to be more complex than they believed. Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi have been awarded the 2025 Nobel Prize in Physiology or Medicine for their discoveries concerning peripheral immune tolerance.
#Metastasis remains the leading cause of #cancer mortality, yet it is still the least understood part of the disease. At Cancer Digital Twins, we are thriving to prevent metastasis with the power of digital replica of tumors. #digitaltwins#personalized#treatment
The sooner cancer is detected, the better the outcome. ⏳
Personalized biomarkers hold the key, for early detection, before it becomes challenging. Cancer Digital Twins is advancing cancer treatment from late discovery ➝ early precision care.
#CancerDigitalTwins#Biomarkers
In addition, Cancer risk includes:🧬 Genetic mutations🧩 Epigenetic changes🔥 Chronic inflammation⏳ Aging
🌍 Lifestyle & environment
At Cancer Digital Twins, we want to cut side effects & improve longevity.
#CancerDigitalTwins#PrecisionOncology
#Cancer treatment saves lives, but it often leaves scars, the journey doesn’t end when treatment does.
At Cancer Digital Twins, we create digital replica to anticipate toxicities, and design more #personalized, safer #therapies.
🌱 #Aging, #Cancer, and Longevity: Rethinking the Future of Care 🌱with Cancer Digital Twins. Our vision add a unique focus: patient longevity and quality of life. Beyond treating the tumor, our mission is to minimize the long-term #sideeffects of cancer therapies. #longevity
Chemobrain, side effect that impact cognitive abilities. At Cancer Digital Twins, we are committed to minimizing these challenges and improving quality of life through virtual therapy design.
#CancerCare#DigitalTwin#PrecisionMedicine
Many oncologists hear from their patients undergoing chemotherapy that they're experiencing "chemobrain".
What the latest research says about this common side effect and its possible causes: https://t.co/XC6KIfFTt9 #EndCancer
Onco-nutrition is a part of cancer management. No child and family should face the burden of treatment side effects alone. At Cancer Digital Twins, we are committed to minimizing these challenges and improving quality of life, at the individual scale.
#DigitalTwin#OncoNutrition
Nutrition counselling saves lives 🥣
Dietitians guide families through meal planning, debunk food myths, and help children manage side effects—ensuring they get the nourishment they need during cancer treatment
Support their work—donate crypto today! https://t.co/EE1hmmUjyp
🎗️ Breast cancer treatments save lives, but survivors often face long-term side effects.
💡 With Cancer Digital Twin technology, we can model individual responses, predict risks, and design safer, more personalized therapies.
#BreastCancer#DigitalTwin#CancerCare
⚡ Radiation therapy saves lives, but its side effects can last a lifetime, impacting health, recovery, and quality of life.
💡 Cancer Digital Twins offers hope: simulating treatment responses, predicting toxicity, and personalizing care to minimize harm.
#CancerCare#DigitalTwin
Radiation therapy is one of the most common and effective treatments for cancer. However, radiation can also lead to side effects some of which may not appear until months after treatment has ended. Here’s how to understand them:
https://t.co/r8tZoHESIF
#InterferonPower! Thrilled for our latest work @CellCellPress! With @dfrboehmer, we dug into tons of papers & created what we hope will be a go-to resource for immunologists & non-immunologist about type I, II, III (& IV😉) #interferons! Free link 👉 https://t.co/gYwGir0npB
🧠 Dr. Yusuke Suita and team at @BrownUniversity suggested that glioblastoma stem cells share a common distributional pattern of enhancer activity characterized by H3K27Ac.
@PLOSCompBiol | https://t.co/D3CJhFELTb
Results from an MD Anderson study suggest that targeting the signaling pathways between cancer and the nervous system can reverse inflammation and improve treatment responses: https://t.co/vTOJvPOcVx @moranamit2#EndCancer